company background image
EVH

Evolent HealthNYSE:EVH Stock Report

Last Price

US$22.76

Market Cap

US$2.0b

7D

-13.0%

1Y

26.6%

Updated

21 Jan, 2022

Data

Company Financials +
EVH fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance0/6
Financial Health4/6
Dividends0/6

EVH Stock Overview

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States.

Evolent Health Competitors

Cerner

NasdaqGS:CERN

US$26.8b

Inovalon Holdings

NasdaqGS:INOV

US$6.4b

Change Healthcare

NasdaqGS:CHNG

US$6.3b

Allscripts Healthcare Solutions

NasdaqGS:MDRX

US$2.1b

Price History & Performance

Summary of all time highs, changes and price drops for Evolent Health
Historical stock prices
Current Share PriceUS$22.76
52 Week HighUS$34.60
52 Week LowUS$16.81
Beta2.11
1 Month Change-12.73%
3 Month Change-24.69%
1 Year Change26.58%
3 Year Change29.39%
5 Year Change26.09%
Change since IPO20.68%

Recent News & Updates

Nov 05
Is Evolent Health (NYSE:EVH) Using Too Much Debt?

Is Evolent Health (NYSE:EVH) Using Too Much Debt?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Shareholder Returns

EVHUS Healthcare ServicesUS Market
7D-13.0%-4.3%-4.0%
1Y26.6%-31.3%6.6%

Return vs Industry: EVH exceeded the US Healthcare Services industry which returned -31.4% over the past year.

Return vs Market: EVH exceeded the US Market which returned 7.7% over the past year.

Price Volatility

Is EVH's price volatile compared to industry and market?
EVH volatility
EVH Average Weekly Movement6.6%
Healthcare Services Industry Average Movement10.2%
Market Average Movement6.6%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market2.4%

Stable Share Price: EVH is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: EVH's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20112,900Seth Blackleyhttps://www.evolenthealth.com

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates through two segments, Services and True Health. The Services segment provides value-based care services that include Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows and engages patients; population health performance that delivers patient-centric cost effective care; and delivery network alignments.

Evolent Health Fundamentals Summary

How do Evolent Health's earnings and revenue compare to its market cap?
EVH fundamental statistics
Market CapUS$2.00b
Earnings (TTM)-US$50.87m
Revenue (TTM)US$1.00b

2.0x

P/S Ratio

-39.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
EVH income statement (TTM)
RevenueUS$1.00b
Cost of RevenueUS$760.65m
Gross ProfitUS$243.28m
ExpensesUS$294.15m
Earnings-US$50.87m

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.58
Gross Margin24.23%
Net Profit Margin-5.07%
Debt/Equity Ratio39.1%

How did EVH perform over the long term?

See historical performance and comparison

Valuation

Is Evolent Health undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: EVH ($22.76) is trading below our estimate of fair value ($49.16)

Significantly Below Fair Value: EVH is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: EVH is unprofitable, so we can't compare its PE Ratio to the US Healthcare Services industry average.

PE vs Market: EVH is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate EVH's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: EVH is good value based on its PB Ratio (3.3x) compared to the US Healthcare Services industry average (3.4x).


Future Growth

How is Evolent Health forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?

74.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: EVH is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2%).

Earnings vs Market: EVH is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: EVH's is expected to become profitable in the next 3 years.

Revenue vs Market: EVH's revenue (15.7% per year) is forecast to grow faster than the US market (9.3% per year).

High Growth Revenue: EVH's revenue (15.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if EVH's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Evolent Health performed over the past 5 years?

-28.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: EVH is currently unprofitable.

Growing Profit Margin: EVH is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: EVH is unprofitable, and losses have increased over the past 5 years at a rate of 28% per year.

Accelerating Growth: Unable to compare EVH's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: EVH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (16.1%).


Return on Equity

High ROE: EVH has a negative Return on Equity (-8.24%), as it is currently unprofitable.


Financial Health

How is Evolent Health's financial position?


Financial Position Analysis

Short Term Liabilities: EVH's short term assets ($478.2M) exceed its short term liabilities ($367.2M).

Long Term Liabilities: EVH's short term assets ($478.2M) exceed its long term liabilities ($278.8M).


Debt to Equity History and Analysis

Debt Level: EVH has more cash than its total debt.

Reducing Debt: EVH's debt to equity ratio has increased from 0.2% to 39.1% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: EVH has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if EVH has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Dividend

What is Evolent Health current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate EVH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate EVH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if EVH's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if EVH's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of EVH's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.0yrs

Average management tenure


CEO

Seth Blackley (42 yo)

11yrs

Tenure

US$3,972,700

Compensation

Mr. Seth Barrie Blackley serves as Chief Executive Officer at Evolent Health, Inc. since October 1, 2020. He serves as President of True Health Indiana, Inc. (True Health Indiana). Mr. Blackley co-founded...


CEO Compensation Analysis

Compensation vs Market: Seth's total compensation ($USD3.97M) is about average for companies of similar size in the US market ($USD3.72M).

Compensation vs Earnings: Seth's compensation has increased whilst the company is unprofitable.


Leadership Team

Experienced Management: EVH's management team is considered experienced (3 years average tenure).


Board Members

Experienced Board: EVH's board of directors are considered experienced (4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.2%.


Top Shareholders

Company Information

Evolent Health, Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Evolent Health, Inc.
  • Ticker: EVH
  • Exchange: NYSE
  • Founded: 2011
  • Industry: Health Care Technology
  • Sector: Healthcare
  • Implied Market Cap: US$2.000b
  • Shares outstanding: 87.87m
  • Website: https://www.evolenthealth.com

Number of Employees


Location

  • Evolent Health, Inc.
  • 800 North Glebe Road
  • Suite 500
  • Arlington
  • Virginia
  • 22203
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/01/21 00:11
End of Day Share Price2022/01/20 00:00
Earnings2021/09/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.